DELIA BEHPOUR: Open Payments
NPI 1831840552 · PORT MATILDA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$527 in 19 payments from 14 companies in 2025. Trend: 2023 $325 · 2024 $1,271 · 2025 $527
Food & beverage: $527
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 6 | $152 |
| Neurelis, Inc. | 1 | $124 |
| Astellas Pharma US Inc | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Genentech USA, Inc. | 1 | $24 |
| Agios Pharmaceuticals, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| SOBI, INC | 1 | $20 |
Products named: Enhertu, VALTOCO, XTANDI, Vanflyta, KEYTRUDA, Polivy, PYRUKYND, ICLUSIG.
Industry payments across PA — which companies pay providers there.
